glp-1 obesity drug news oct 21 2025 2024 was a record year for trials and is already poised to take over New Daily GLP-1 Weight Loss
Description
Mir Ali, MD, medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, calls NAION a rare and unusual side effect of semaglutide, noting that the vast majority of people who use this medication dont experience the eye condition
Sikirica M, Martin A, Wood R, Leith A, Piercy J, Higgins V
Consider your practical constraints
Morris JK, Bomhoff GL, Gorres BK, Davis VA, Kim J, Lee PP, et al
Treatments must align with metabolic physiology, behavioural science, and sustainable lifestyle adjustments to achieve real, lasting results
Most of this weight settles around the abdomen and upper body, which isnt just about appearance its about health
